|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
1.290 +0.020 (+1.575%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 03/2025 | EPS | 15.15 HKD (cts) | |
| Net Profit | 300.83 HKD (MIL) | DPS | 15.00 HKD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (HKD (MIL)) |
EPS/ ((LPS)(HKD (cts)) |
DPS (HKD (cts)) |
Net Asset Value per Share (HKD) |
Highest (HKD (MIL)) |
Lowest (HKD (MIL)) |
| 2026 | 288.91 | 14.50 | 8.70 | -- | 288.91 | 288.91 |
| 2027 | 322.44 | 16.20 | 9.70 | -- | 322.44 | 322.44 |
| 2028 | 363.45 | 18.20 | 10.90 | -- | 363.45 | 363.45 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (HKD (MIL)) |
EPS*/ (LPS) (HKD (cts)) |
DPS * (HKD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 288.91 | 14.50 | 8.70 | UOB | Buy | 2.53 | 21/11/2025 | |
| 2027 | 322.44 | 16.20 | 9.70 | UOB | -- | -- | 21/11/2025 | |
| 2028 | 363.45 | 18.20 | 10.90 | UOB | -- | -- | 21/11/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 12/12/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 142,035 |
| %Change | 1.244% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 1.117 |